首页> 外文期刊>Journal of radiological protection: Official journal of the Society for Radiological Protection >Patient skin dose measurements during coronary interventional procedures using Gafchromic film
【24h】

Patient skin dose measurements during coronary interventional procedures using Gafchromic film

机译:使用Gafchromic胶片在冠状动脉介入手术期间测量患者的皮肤剂量

获取原文
获取原文并翻译 | 示例
           

摘要

Interventional cardiology (IC) procedures are known to give high radiation doses to patients and cardiologists as they involve long fluoroscopy times and several cine runs. Patients' dose measurements were carried out at the cardiology department in a local hospital in Penang, Malaysia, using Gafchromic XR-RV2 films. The dosimetric properties of the Gafchromic film were first characterised. The film was energy and dose rate independent but dose dependent for the clinically used values. The film had reproducibility within ±3% when irradiated on three different days and hence the same XRRV2 dose-response calibration curve can be used to obtain patient entrance skin dose on different days. The increase in the response of the film post-irradiation was less than 4% over a period of 35 days. For patient dose measurements, the films were placed on the table underneath the patient for an under-couch tube position. This study included a total of 44 patients. Values of 35-2442 mGy for peak skin dose (PSD) and 10.9-344.4 Gy cm~2 for dose-area product (DAP) were obtained. DAP was found to be a poor indicator of PSD for PTCA procedures but there was a better correlation (R~2 = 0.7344) for CA + PTCA procedures. The highest PSD value in this study exceeded the threshold dose value of 2 Gy for early transient skin injury recommended by the Food and Drug Administration.
机译:众所周知,介入心脏病学(IC)程序会给患者和心脏病专家带来高辐射剂量,因为它们需要较长的透视时间和数次放映。使用Gafchromic XR-RV2胶片在马来西亚槟城当地一家医院的心脏病科进行剂量测量。首先对Gafchromic薄膜的剂量特性进行了表征。该膜是能量和剂量率无关的,但剂量取决于临床使用的值。在三天不同的时间照射时,该膜的再现性在±3%以内,因此可以使用相同的XRRV2剂量反应校准曲线来获得不同日期的患者入院皮肤剂量。在35天的时间内,膜辐照后响应的增加少于4%。为了测量患者的剂量,将膜放在患者下方的桌子上,放在沙发下管位置。该研究共包括44名患者。获得的峰值皮肤剂量(PSD)值为35-2442 mGy,剂量面积乘积(DAP)值为10.9-344.4 Gy cm〜2。发现DAP不能很好地指示PTCA程序的PSD,但CA + PTCA程序的相关性更好(R〜2 = 0.7344)。在这项研究中,最高PSD值超过了美国食品药品管理局(FDA)推荐的早期短暂性皮肤损伤阈值剂量2 Gy。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号